|Day Low/High||64.39 / 64.89|
|52 Wk Low/High||43.96 / 74.70|
The Russell 2000 has now soared 16% year to date, nearly twice the Nasdaq Composite's 8.5% move.
As power has changed hands in the White House, we can expect these names -- and themes -- to benefit.
Here's our analysis and trading strategy for CNC shares.
While the market appears to be enjoying the election results (so far), here's my take on electric vehicles, health care, metals and restaurants.
These are the top five misconceptions about presidential elections -- and the stocks that you should look at right now.
Here I'll show you why the best buys are often only available when you're too scared to buy them.
Let's check the charts of the health plan provider.
Neither candidate seems to be the enemy of the market -- at least not yet.
Follow fundamentals and ignore the attempts to gaslight you into not believing your own projections.
Centene is a $110 billion in revenue company you've probably never heard of. Here's how to play it.
Technical analysis and trading strategy for the healthcare plan provider.
Let's go over the confluence that allowed us to advance after a brief dip down in the morning.
Overall the charts of CNC are constructive but I would still want to buy strength.
Money movers are not buying protection for individual names, but they are starting to bet against the market en masse, while the Russell 2000 ran up 4% on Monday.
You can sell any stock that's up and take that money to the bank and no one will say, "sorry that was made off of euphoria, we can't take it."
Let's see what the charts look like the day after the State of the Union address.
These are the 10 reasons why we keep going up, despite all the bad news.
The nation enters an electoral season. The drug companies for the most part, have no friends on either side of the aisle.
It is early in the game but here's what traders can do.
A little bit of luck and a lot of homework can go a long way to make Big Money out of Mad Money. It's buying a Biogen, a Centene, or a Bristol-Myers that could do just that for you.
There is a chance that Presidents Trump and Xi sign something when they meet up at the APEC summit this November in Santiago, Chile.
Downside momentum has been slowing in the healthcare company's shares, which could foreshadow a low or a reversal.
Also, defense industry names can breathe easier with word of debt ceiling and federal spending deal.
A rally above the highs of April and May or above $58 will be positive for the provider of healthcare programs.
A look at the charts and indicators of three big names in the sector .
These managed care stocks can withstand China, politics and a slowdown in the economy.